MAI Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

MAI Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-776	Closed	-$10.7K	–	4126
2026 Q1	$10.7K	Buy	776 +147	+23%	+$2.05K	﹤0.01%	3139
2025 Q4	$8.83K	Sell	629 -1,463	-70%	-$20.5K	﹤0.01%	2906
2025 Q3	$29.2K	Sell	2,092 -11,230	-84%	-$162K	﹤0.01%	2228
2025 Q2	$200K	Buy	13,322 +13,267	+24,122%	+$189K	﹤0.01%	1176
2025 Q1	$726	Hold	55	–	–	﹤0.01%	3188
2024 Q4	$869	Buy	+55	New	+$826	﹤0.01%	3226
2024 Q3	–	Sell	-16,925	Closed	-$258K	–	1218
2024 Q2	$258K	Sell	16,925 -1,565	-8%	-$22.4K	﹤0.01%	1041
2024 Q1	$271K	Buy	18,490 +3,450	+23%	+$50.4K	﹤0.01%	1009
2023 Q4	$209K	Buy	+15,040	New	+$201K	﹤0.01%	1007

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

MAI Capital Management's RDY Position: Q2 2026 in Review

MAI Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 776 shares — an estimated $10.7K sold.

MAI Capital Management first reported a position in RDY in Q4 2023 and held it in 9 quarters. The position peaked at $271K in Q1 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

MAI Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 776 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $10.7K.
MAI Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2023 and held it in 9 quarters.
MAI Capital Management's Dr. Reddy's Laboratories position peaked at $271K in Q1 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.